Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022

SELL
$25.61 - $110.96 $319,228 - $1.38 Million
-12,465 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$94.25 - $132.81 $386,425 - $544,521
4,100 Added 49.01%
12,465 $1.24 Million
Q4 2020

Feb 05, 2021

SELL
$102.03 - $184.62 $383,632 - $694,171
-3,760 Reduced 31.01%
8,365 $1.13 Million
Q3 2020

Oct 27, 2020

BUY
$93.53 - $163.34 $1.13 Million - $1.98 Million
12,125 New
12,125 $1.18 Million

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Am Investment Strategies LLC Portfolio

Follow Am Investment Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Am Investment Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Am Investment Strategies LLC with notifications on news.